CYTOKINETICS INC
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
CYTK$56.18+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
| Nine Months Ended | ||
|---|---|---|
| September 30, 2026 | September 30, 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(594,862) | $(601,924) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Non-cash interest expense on liabilities related to revenue participation right purchase agreements | 62,659 | 42,306 |
| Stock-based compensation expense | 100,826 | 81,780 |
| Non-cash lease expense | 4,974 | 4,038 |
| Depreciation of property and equipment | 10,657 | 7,264 |
| Change in fair value of derivative liabilities | 200 | (3,300) |
| Change in fair value of liabilities related to RPI Transactions | (1,000) | 13,500 |
| Realized gain on investment, net | (184) | (17) |
| Interest receivable and amortization on investments | (10,507) | (12,902) |
| Non-cash interest expense related to debt | 26,161 | 14,431 |
| Debt conversion expense | — | 121,249 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (16,125) | 14,842 |
| Prepaid and other assets | (7,899) | 1,264 |
| Inventories | (15,112) | — |
| Accounts payable | 6,741 | 2,972 |
| Deferred revenue | 41 | (50,758) |
| Accrued and other liabilities | 24,112 | 7,235 |
| Operating lease liabilities | (6,583) | (6,616) |
| Other non-current liabilities | (13,417) | (2,722) |
| Net cash used in operating activities | (429,318) | (367,358) |
| Cash flows from investing activities: | ||
| Purchases of investments | (986,253) | (717,523) |
| Investment in non-marketable equity security | — | (5,000) |
| Maturities of investments | 703,642 | 823,551 |
| Sales of investments | — | 5,993 |
| Purchases of property and equipment | (10,964) | (19,163) |
| Net cash (used in) provided by investing activities | (293,575) | 87,858 |
| Cash flows from financing activities: | ||
| Repayment of finance lease liabilities | — | (204) |
| Repayment of term loans | (11,736) | (8,087) |
| Payments of royalty obligations | (1,500) | — |
| Repayment of convertible debt | — | (402,500) |
| Proceeds from issuance of convertible debt, net | — | 729,460 |
| Proceeds from borrowing under term loans | — | 75,000 |
| Proceeds from issuance of common stock related to public offering, net of issuance costs | 760,148 | — |
| Proceeds from issuance of common stock under equity incentive and stock purchase plans | 61,757 | 21,331 |
| Taxes paid related to net share settlement of equity awards | (3,242) | (1,247) |
| Net cash provided by financing activities | 805,427 | 413,753 |
| Effect of exchange rate changes on cash | (1,637) | (906) |
| Net increase in cash, cash equivalents, and restricted cash | 80,897 | 133,347 |
| Cash, cash equivalents, and restricted cash, beginning of period | 125,632 | 95,232 |
| Cash, cash equivalents, and restricted cash, end of period | $206,529 | $228,579 |
| Supplemental cash flow disclosures: | ||
| Cash paid for interest | $12,546 | $19,874 |
| Non-cash investing and financing activities: | ||
| Right-of-use assets recognized in exchange for operating lease obligations | $663 | $6,427 |
| Amounts unpaid for purchases of property and equipment | $410 | $2,088 |
| Conversion of 2026 Notes | $21,067 | $— |
| Issuance of common stock in connection with repurchase of convertible note | $— | $107,920 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.